Author: CannabisNewsWire (CNW)

About CannabisNewsWire CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge. To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only) For more information please visit https://www.CannabisNewsWire.com Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsBreaks – AmeriCann Inc.’s (ACAN) Massachusetts Cannabis Center Featured on Award-Winning Series

AmeriCann (OTCQB: ACAN), a cannabis company that develops state-of-the-art cultivation, product manufacturing and distribution facilities, today announced that its Massachusetts Cannabis Center was featured on the award-winning series by Dr. Sanjay Gupta on CNN exploring cannabis treatments for autism. “For nearly a decade Dr. Sanjay Gupta’s breakthrough series has shattered myths and introduced the healing properties of cannabis on a global stage,” said AmeriCann CEO Tim Keogh. “We are proud to play a role in helping Dr. Gupta present the considerable benefits that severe autism patients have achieved being treated with cannabis.” To view the full press release, visit https://cnw.fm/fIF9L About AmeriCann Inc. AmeriCann develops and leases cannabis cultivation, processing and product manufacturing facilities. The company uses greenhouse technology, which is superior to the current industry standard of growing cannabis in warehouse facilities under artificial lights. According to industry experts, by capturing natural sunlight, greenhouses use 25% fewer lights, and utility bills are up to 75% less than in typical warehouse cultivation facilities. As such, AmeriCann’s “Cannopy” cultivation system enables cannabis to be produced with a greatly reduced carbon footprint, making the final product less expensive. Additionally, greenhouse construction costs are nearly half of warehouse construction costs. AmeriCann is also designing GMP certified cannabis extraction and product manufacturing infrastructure. The company has secured licenses to produce cannabis infused products including beverages, edibles, topicals and concentrates. AmeriCann plans to operate a marijuana product manufacturing business at the Massachusetts Cannabis Center. For more information about the company, visit www.AmeriCann.co. About CannabisNewsWire CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge. To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only) For more information please visit https://www.CannabisNewsWire.com Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer Do you have questions or are you interested in working with CNW? Ask our Editor CannabisNewsWire (CNW) Denver, Colorado www.CannabisNewsWire.com 303.498.7722 Office Editor@CannabisNewsWire.com CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Partners with Avicanna to Launch New Derma-Cosmetic Brand

Red White & Bloom (CSE: RWB) (OTCQX: RWBYF), a multistate cannabis operator and house of premium brands, is working with Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) to unveil a new THC-free, CBD derma-cosmetic brand. The first known CBD skincare line to be clinically tested and commercialized across four international markets, Pura H&W will include seven SKUs of proprietary products. The products are formulated using a combination of purified CBD and other synergistic botanical ingredients designed to naturally regulate and nourish the skin. The Pura H&W product line was developed by Avicanna and specific products have undergone clinical trials. The products are available under Pura H&W or Pura Earth in Canada, Colombia, Ecuador and the U.S. Consumers can purchase Pura H&W products online as well as from both cannabis and noncannabis specific retailers. Avicanna is a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based pharmaceuticals. “We are excited to launch the Pura brand in the U.S., said Red White & Bloom CEO Brad Rogers in the press release. “As the first clinically tested line in CBD cosmetics, the reaction from our stores and retail partners has been exciting and this is strategically aligned with our goal to be the most recognized and responsible multi state operator (MSO) in the market. We look forward to scaling the launch quickly in both our physical and digital channels.”

To view the full press release, visit https://cnw.fm/KQVAC

About Red White & Bloom Brands Inc.

Red White & Bloom Brands is positioning itself to be one of the top-three multistate cannabis operators active in the U.S. legal cannabis and hemp sectors. RWB is predominantly focusing its investments on major U.S. markets, including Michigan, Illinois, California and Florida with respect to cannabis, as well as the United States and internationally for hemp-based CBD products. For more information about the company, please visit www.RedWhiteBloom.com.

NOTE TO INVESTORS: The latest news and updates relating to RWBYF are available in the company’s newsroom at https://cnw.fm/RWBYF

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — Malta Becomes First Country in EU to Legalize Marijuana

Malta, an island-state located in the Mediterranean Sea, has become the first nation in the European Union to legalize the personal use and growing of marijuana. This move by Malta comes after the United Nations reclassified marijuana to recognize its therapeutic use in 2020.

Adults in the country will be allowed to grow a maximum of four plants in their homes and be in possession of up to seven grams of marijuana. However, smoking the herb in front of children or smoking it in public remains illegal.

The parliament of Malta voted in favor of the measure to legalize earlier this week, approving the reform with a vote of 36 to 27. Owen Bonnici, the country’s equality minister, stated that the move would prevent small-time users of marijuana from being arrested and limit drug trafficking by ensuring that users had a regularized and safe way to obtain marijuana.

The Nationalist Party, the country’s opposition party, voted against the reform. Bernard Grech, the opposition party’s leader, had warned that the reform would strengthen the illicit drug market and allow organized crime to take advantage.

Despite its approval in parliament, opponents are calling for President George Vella to not sign the reform into law. Signing the measure into law is the final stage, which requires the president’s approval.

Under the new law, any individual found in possession of more than 7 grams but less than 28 grams of cannabis could receive a fine of up to €100, which is equal to $112. Those caught smoking marijuana in front of any person below 18 will be fined €500 ($659) while those caught smoking in public will be fined €235 ($310).

Additionally, associations that will oversee the distribution of seeds to grow marijuana or the drug will be established. Legislators believe that this will regulate how much an individual can purchase, as every individual will be allowed to be a member of only a single association.

Minors found in possession of marijuana will, instead of facing criminal charges or arrest, be recommended with a treatment of care plan.

The first country to legalize marijuana for personal use globally was Uruguay, which legalized the subtance in 2013, with Canada following suit in 2018. Several other countries, including Switzerland, Luxembourg and Germany, recently announced their plans to set up legally regulated markets.

Nations such as the Netherlands tolerate the use of marijuana in its famous marijuana cafes, despite the plant being illegal in the country. In the United States, some states have legalized marijuana for recreational and/or medical use. However, the herb is still federally illegal.

For companies such as BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) that have their eye on a large market spanning different jurisdictions, Malta’s decision to end cannabis prohibition can be seen as a watershed moment since several other countries in the EU are likely to follow suit.

NOTE TO INVESTORS: The latest news and updates relating to BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) are available in the company’s newsroom at http://cnw.fm/BVNNF

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Why Cannabis May Be Helpful During Opioid Recovery

The opioid epidemic has wreaked havoc across America for nearly two decades. From 1999 to 2019, opioid overdoses claimed 841,000 lives and reached a record high of 93,000 lives lost during the coronavirus pandemic in 2020. Even though we’ve known about the opioid epidemic for more than 20 years, we are still a long way from finding an effective alternative for pharmaceuticals and eliminating overdose deaths. Ironically, one of the most controversial plants in the country may be the key to helping people recover from opioid addiction.

Dozens of states now allow qualifying patients to use medical marijuana as a treatment for a variety of health issues. Although cannabis research is still in its infancy, several studies have found that cannabis can be effective against certain conditions. With no end to the opioid crisis in sight, cannabis may be used to help people who have become addicted to opioids overcome the addiction. Several legislators are already working on federal cannabis legalization, and the plant may soon be decriminalized and even more accessible to the general public than it is now.

But how exactly does cannabis aid in opioid recovery? For starters, it can be quite effective against the one symptom that keeps addicts from recovering: withdrawal. Opioid withdrawal symptoms can be brutal. How long withdrawal symptoms last typically depends on the type of drug, amount, and frequency of use. However, cannabis can ease these symptoms and make the initial period of treatment, which can be challenging, more bearable. Studies have shown that it can relieve common withdrawal symptoms such as chronic pain, insomnia, anxiety and nausea.

Cannabis can also be effective at reducing and even eliminating opioid cravings. While everyone has everyday cravings, we can usually choose whether or not to act on them. However, it can be hard to fight cravings for addictive substances such as nicotine, alcohol and opioids once an individual is hooked. A recent study on heroin use disorder found that cannabis can reduce drug cravings and anxiety in patients recovering from opioid addiction. Test subjects exhibited a reduction in opioid craving as well as anxiety for a week after taking a dose of cannabidiol (“CBD”).

Finally, cannabis can improve the quality of life of individuals recovering from opioid addiction. Opioid withdrawal symptoms range from uncomfortable to severe and can last for months. Cannabis can ease all the negative effects of opioid withdrawal during this period and help patients regain their lives as they were before addiction set in.

The possibility that marijuana products could be helpful to those battling opioid dependence makes it worthwhile for rigorous research to be done using products manufactured by entities such as American Cannabis Partners since this is what people access when they pay a dispensary a visit in states where marijuana is legal.

NOTE TO INVESTORS: The latest news and updates relating to American Cannabis Partners are available in the company’s newsroom at https://cnw.fm/ACP

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Pursuing Regulatory Approvals for DehydraTECH(TM), Entry into Different Markets

Lexaria Bioscience Corp. (NASDAQ: LEXX) is embarking on new programs as well as extending ongoing ones as it pursues regulatory approvals and entry into different market sectors. In January 2022, the company expects to report blood pressure findings from its third human hypertension study, HYPER-H21-3, building on the successes of the first two human studies that evidenced effective, sustained and safe blood pressure reduction with DehydraTECH-CBD. The company will also be expecting approvals for the protocols around its fourth hypertension study, HYPER-H21-4, which is just one of the many planned studies slated for 2022. “Others include HOR-A22-1, a pharmacokinetic study to evaluate DehydraTECH’s ability to improve the delivery characteristics of estrogen; DEM-A22-1, an efficacy modeling study to evaluate DehydraTECH-CBD with and without nicotine for the potential treatment of dementia; RHEUM-A22-1, an efficacy modeling study to investigate the ability of DehydraTECH-CBD to potentially affect the treatment of rheumatoid disease; and DIAB-A22-1, an efficacy modeling study to explore DehydraTECH-CBD’s ability to potentially impact treatment of diabetes,” explains a recent article. “In addition to fulfilling Lexaria’s goal to enter into new, different multibillion markets, the four animal studies will mark the company’s push to help patients living with these conditions, some of which are potentially fatal.”

To view the full article, visit https://cnw.fm/93Tti

About Lexaria Bioscience Corp.

Lexaria’s patented drug delivery technology, DehydraTECH(TM), improves the way active pharmaceutical ingredients (“APIs”) enter the bloodstream by promoting more effective oral delivery. Since 2016, DehydraTECH has repeatedly demonstrated the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce time of onset from one to two hours to minutes, and mask unwanted tastes. The technology is also being evaluated for orally administered anti-viral drugs, non-steroidal anti-inflammatory drugs (“NSAIDs”), PDE5 inhibitors and more. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio with 23 patents granted and over 50 patents pending worldwide. For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://cnw.fm/LEXX

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — Does CBD Support Post-Cancer Recovery?

You have probably heard about CBD, either from the media or in person, especially in regard to its medical potential. Cannabidiol (“CBD”) came into the limelight when the 2018 farm bill federally legalized the cultivation and sale of industrial hemp and its derivatives, including CBD. Although hemp is in the cannabis family, CBD extracted from legal industrial hemp will not intoxicate you. However, CBD still shares plenty of medical properties with THC, the main psychoactive agent in marijuana, and several studies have found that cannabidiol can aid in post-cancer recovery.

So how exactly does taking CBD aid in post-cancer recovery? It all boils down to potent anti-inflammation and antioxidant properties. CBD is most commonly used to address issues such as chronic pain, anxiety, depression, nausea and insomnia. Some studies have also found that cannabinoids such as CBD can inhibit tumor growth and reduce tumor invasion. However, more research is needed before we can conclusively state that CBD is an effective anti-cancer treatment. However, at the moment, cannabinoid does look to be able to support post-cancer recovery.

Coincidentally, most of the adverse symptoms caused by cancer treatments such as radiation and chemotherapy can be treated by CBD treatment. These symptoms include nausea, insomnia, loss of appetite and neuropathic pain. Recovering from cancer can be brutal as the treatments aren’t easy on the body. Lack of appetite, for instance, can significantly reduce your food intake, reducing your energy levels and actually hindering your recovery. Since CBD is known to stimulate appetite, individuals undergoing cancer treatment can use it to maintain sufficient nutrient intake and give their bodies the energy it needs to recover.

This is the same for insomnia, which will not only make you feel tired and fatigued but can also put your health at even more risk. CBD is also thought to be a pain reliever, and it can be effective against the sometimes severe pain cancer patients feel. All cannabinoids, including CBD and THC, create their therapeutic effects by interacting with the endocannabinoid system (“ECS”), a part of the nervous system that’s in charge of regulating processes such as hunger, sleep and pain. Essentially, the ECS is a system that works to maintain homeostasis, or the body’s internal balance.

If you would like to use CBD to aid in cancer recovery, make sure to speak to your doctor first. Additionally, you should not ditch your cancer medication for CBD; while some studies have found that it has anti-cancer effects, it isn’t an effective treatment against cancer.

Such cannabis-based treatments may stand a higher chance of being beneficial when taken using an IoT-enabled dose-measuring device such as those produced by RYAH Group Inc. (CSE: RYAH) and other such companies.

NOTE TO INVESTORS: The latest news and updates relating to RYAH Group Inc. (CSE: RYAH) are available in the company’s newsroom at https://cnw.fm/RYAH

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Marijuana Industry Expects to See Spike in Sales This Holiday Season

The holiday season is here, and while most industries will see a slight decline in profits, marijuana sales are expected to go up. Reports from Leaflink show that cannabis sales rose by more than 30% in the week leading up to Christmas last year, in comparison to the previous four weeks of 2020. Additionally, sales on Christmas Eve last year rose by 61%, in comparison to the previous four Thursdays.

Leaflink, a unified marijuana platform, also reports that on the days leading up to Green Wednesday November, they saw an increase of more than 10% in sales. If sales from Green Wednesday are any indication, the cannabis market will see a significant jump in sales this year.

Glass House Brands Inc., a company based in California, also saw an increase of more than 40% in its sales across its locations on Green Wednesday, compared to the 2020 sales day. This was the same case for Jushi Holdings Inc. and Beyond Hello, its retail brand, which saw an increase of more than 110% in Green Wednesday sales, in comparison to the prior year’s sales.

The rep for Terrasana, a dispensary chain in Ohio, stated recently that the company expects December to be its highest-grossing month in 2021. Expectations grew after Terrasan increased transactions and revenue by 33% and 23% respectively in November.

eCommerce retailers also expect sales to increase this month. Tyler Browne, the owner of To the Cloud, an online retail vapor store based in California, stated that he expected sales in December to be good for the whole marketplace, in particular those looking to begin anew next year. He added that while sales for 4/20 in April were great, marijuana was becoming mainstream, which caused the weed holiday to be less impressive because every day was 4/20 for most consumers.

However, not every part of the marijuana industry sees an increase in sales during the holidays. For instance, cultivators are busiest in April because that’s the time for harvest and in October, when new cultivators are introduced. Once the plant is harvested, other companies are given the task of processing and packaging the product.

Grove Bags is one of the companies that does this. Chief of Staff Jeffrey Eisenstodt revealed that the company’s busy season began in the summer and peaked in September or October. He added that while the holiday season was good for marijuana purchasing, it marked the end of the harvest season and a downturn in demand for packaging.

Not every company is likely to see a meaningful spike in their sales activity this festive season, unless they have gone out of their way to manufacture the best possible products while also nurturing their brand in the way that some leading entities, such as Cannabis Strategic Ventures Inc. (OTC: NUGS), have been doing.

NOTE TO INVESTORS: The latest news and updates relating to Cannabis Strategic Ventures Inc. (OTC: NUGS) are available in the company’s newsroom at http://cnw.fm/NUGS

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) Ranks in List of Top 101 Canadian F&B Startups and Companies

BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC), an emerging leader in innovative health and wellness beverages and products, has been named one of the 101 Top Food and Beverage Startups and Companies in Canada by Best Startup Canada. The ranking recognizes the company’s leadership position within both the food & beverage and cannabis product categories. Companies listed in the rankings include cutting-edge startups and established brands alike, but each company is known for innovation within their sector, exceptional growth and societal impact. BevCanna was within the group of selected companies that exhibited exceptional performance. In addition, BVNNF was also included within the list of the Top 101 Cannabis Startups and Companies in Canada, a list of innovators and growth companies within the Canadian cannabis industry. In addition, the company has appointed Howard Blank and Douglas Mason as members of the audit committee resulting from their respective appointments as directors at the annual general and special meeting of the shareholders on November 24, 2021. “It’s both an honor and a reflection of the BevCanna team’s expertise and dedication, to be included within the sphere of other premier Canadian food and beverage companies, including Ritual, Goodfood, Flow Water, Chef’s Plate and David’s Tea,” said BevCanna CEO Marcello Leone in the press release. “This recognition of our leadership position within both the food and beverage and the cannabis products categories validates our strategy of developing innovative, highly-customized beverage products that appeal to a range of target markets, including value, craft and premium positioning, for both our in-house brands and our white-label clients.” To view the full press release, visit https://cnw.fm/neDae About BevCanna Enterprises Inc. BevCanna Enterprises is a diversified health and wellness beverage and natural products company. BevCanna develops and manufactures a range of alkaline, plant-based and cannabinoid beverages and supplements for both in-house brands and white-label clients. With decades of experience creating, manufacturing and distributing iconic brands that resonate with consumers on a global scale, the BevCanna team demonstrates an expertise unmatched in the nutraceutical and cannabis-infused beverage categories. Based in British Columbia, BevCanna owns a pristine alkaline spring water aquifer and a world-class, 40,000-square-foot, HACCP-certified manufacturing facility, with a bottling capacity of up to 210 million bottles annually. BevCanna’s extensive distribution network includes more than 3,000 points of retail distribution through its market-leading TRACE brand, its Pure Therapy natural health and wellness e-commerce platform, its fully licensed Canadian cannabis manufacturing and distribution network, and a partnership with number-one U.S. cannabis beverage company Keef Brands. For more information about the company, please visit www.BevCanna.com. NOTE TO INVESTORS: The latest news and updates relating to BVNNF are available in the company’s newsroom at http://cnw.fm/BVVNF About CannabisNewsWire CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge. To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only) For more information please visit https://www.CannabisNewsWire.com Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer Do you have questions or are you interested in working with CNW? Ask our Editor CannabisNewsWire (CNW) Denver, Colorado www.CannabisNewsWire.com 303.498.7722 Office Editor@CannabisNewsWire.com CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — Florida Bipartisan Bill Seeks to Reform Medical Cannabis Program

State cannabis laws have always been tricky; in most cases, they arise from voter-approved initiatives, and their structures are usually determined by lawmakers who largely aren’t fans of cannabis. The result is a lot of push and pull between Republicans and Democrats while consumers sometimes have to contend with a wide variety of subpar, contaminated and even unsafe cannabis products. In Florida, both sides of the political spectrum are setting aside their differences to work on a major cannabis reform bill that would potentially fix an oversight left by the 2018 farm bill.

The farm bill legalized the cultivation and sale of industrial hemp and its derivatives, including CBD. Cannabidiol (“CBD”) has been found to have a variety of medical properties and has even been approved for use in an epilepsy drug called Epidiolex. The federal legislation described industrial hemp as cannabis with less than 0.3% delta-9 THC and required that all hemp products have the same amount of delta-9 THC. However, thanks to a loophole in the bill, hemp products with plenty of delta-8 THC aren’t as regulated, although delta-8 THC is also psychoactive and can cause intoxication.

On top of increasing delta-8 regulation, HB 679 would expand the use of telehealth, restrict medical cannabis advertising, increase the validity of medical cannabis cards from a year to two, and restrict medical marijuana companies from flipping inactive licenses for profit. The bill would also expand testing protocols, establish a Medical Marijuana Testing Advisory Council and require that physicians take a six-hour training course before they can recommend medical marijuana. Representatives Andrew Learned and Spencer Roach are the legislation’s sponsors.

Learned says that Florida’s legislature hasn’t advanced the state’s cannabis sector over the past five years, but their bill is the first step and more are in development. So while the FDA still hasn’t evaluated delta-8 products, HB 679 would require businesses that deal in these products to register them with state authorities and limit their sales to Floridians 21 years of age and older. Agriculture Commissioner Nikki Fried says that the state has to make sure it protects medical cannabis consumers and welcomes the bill’s clarity regarding issues such as product testing.

Learned’s and Roach’s bill is a true compromise, lobbyists and lawmakers say. Both sides won’t get everything they want, but at the end of the day, the bill would be a win for Florida’s medical cannabis program. For example, it doesn’t include a controversial THC cap first introduced by Roach, a Republican, as well as measures including offering workplace protections for medical cannabis patients that are championed by some Democrats. Senators Joe Gruters and Shevrin Jones will soon file a companion bill in the Senate.

These proposed reforms could give entities such as Flora Growth Corp (NASDAQ: FLGC) added impetus to grow due to the additional streamlining of the regulatory regime in the state.

NOTE TO INVESTORS: The latest news and updates relating to Flora Growth Corp. (NASDAQ: FLGC) are available in the company’s newsroom at https://cnw.fm/FLGC

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — ONDCP Director Open to Harm-Reduction Intervention to Manage Overdose Crisis

Top health officials in the Biden administration have been promoting harm reduction for a while now. Recently, the director of the Office of National Drug Control Policy, Rahul Gupta, stated that exploring every option to decrease deaths caused as a results of overdoses was crucial, noting that the options included allowing sites for the safe consumption of illicit substances if evidence supported their effectiveness.

When asked about the launch of a pair of safe consumption sites in the state of New York late last month and whether he supported it, Gupta stated that he was interested in examining the data and science behind the new harm-reduction practices being implemented. He explained that harm reduction was an important tool, given the current crisis, which was why the administration had made it part of its policy.

While the Biden administration’s policy on safe injection sites is still a bit vague, the director’s comments show an openness to harm-reduction intervention. Safe injection sites are controversial in the United States as the federal statute under the constitution known as the crack house statute makes it illegal to use a location to manufacture, distribute or consume controlled substances.

During a briefing on federal harm-reduction grants, Secretary Xavier Becerra of the Department of Health and Human Services was also asked about overdose prevention facilities. When asked about harm-reduction centers, Becerra stated that the administration was examining ways to support research on the efficacy of new practices, noting that they were focused on whether these practices were also effective in real world settings. He added that stigma only induced fear, secrecy and silence, which made it harder to save the lives of those suffering from addiction.

As the conversation on substance misuse and drug policy evolves, the support for the establishment of harm reduction centers continues to grow. A coalition comprised of 80 former and current law enforcement officials and prosecutors have filed a brief that urges the Supreme Court to look into the Safehouse consumption case again. The case involves a Philadelphia not-for-profit organization known as Safehouse, which was sued by the Department of Justice in 2019 to prevent the launch of its safe injection site. Earlier this year, the Supreme Court declined a request to hear a case on the legality of the establishment of said facilities.

Apart from the state of New York, Gov. Daniel McKee of Rhode Island has also signed a measure to establish a safe injection site pilot program.

It might also be beneficial to look into potential benefits marijuana products from licensed actors such as American Cannabis Partners can have in the fight against the overdose crisis since the situation needs concerted efforts from all possible directions.

NOTE TO INVESTORS: The latest news and updates relating to American Cannabis Partners are available in the company’s newsroom at https://cnw.fm/ACP

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.